ANTIDEPRESSANT FOUND IN CABRAL AS NEW DETAILS ON ‘SUICIDE’ PROBE EMERGE

Authorities are examining new details in the investigation into the reported suicide of Cabral, after an antidepressant was found in his system. According to initial data, toxicology screening identified the presence of a medication commonly prescribed for depression and anxiety-related conditions. Officials have not yet released the exact dosage or how long the drug had been in his body prior to death. Investigators are treating the toxicology findings as one element among several pieces of evidence, alongside witness statements and scene documentation.

The case has drawn public interest because it touches on broader issues of mental health, medical treatment, and how deaths are classified by law enforcement. Based on preliminary reports, authorities are reviewing Cabral’s medical history, including any prescriptions and consultations with health professionals. This process typically involves checking pharmacy records and interviewing relatives or close contacts to understand whether the medication was taken as directed. The aim, according to officials, is to determine whether the drug use was consistent with therapeutic care or if there were any irregularities.

Investigators are also verifying whether the antidepressant could have influenced Cabral’s state of mind or physical condition near the time of death. Forensic teams are comparing the toxicology results with other evidence, such as timing, location, and any documented behavior changes, to confirm whether the manner of death aligns with a suicide finding. According to statements from authorities, no final conclusions will be announced until all laboratory analyses and procedural reviews are complete. Until then, the case remains under active review, and officials have emphasized that the toxicology report is informative but not, by itself, determinative.